Gene Therapy Clinical Trials
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
This study is collecting and storing malignant, borderline malignant neoplasms, and related biological samples from young patients with cancer. Collecting and storing samples of tumor tissue, blood, and bone marrow from patients with cancer to study in the laboratory may help the study of cancer in the future.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: cytology specimen collection procedure
Eligibility
Inclusion Criteria:
- Meets any of the following criteria:
- Diagnosed with primary neoplasm
- Developed a second malignant neoplasm
- Any diagnoses having an ICD-O Morphology Code ending in 1, 2, or 3 as listed in
the International Classification of Disease for Oncology, Third Edition
- Must have biological specimens including solid tumors and leukemias available
- Solid tumors meeting the following criteria:
- Snap frozen primary tumor OR OCT embedded primary tumor OR formalin fixed
(block or tissue in formalin) primary tumor AND at least 10 unstained
paraffin slides for NIH Mandated QC (tumors that have undergone central
pathology review are allowed)
- Slides for pathology review (instead of slides for QC) are required for
patients with rare tumors
- Pleural fluid or cytologic specimens meeting the following criteria:
- At least 1 mL of fluid and at least 2 unstained cytospin slides (or 2
unstained smears)
- Slides for pathology review (instead of slides for QC) are required for
patients with rare tumors
- ALL/AML
- 3-6 mL of bone marrow aspirate and 10 mL of whole blood
- Not eligible for disease-specific biology or banking protocol
Ages Eligible for Study
N/A - 30 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
CCTO
650-498-7061
Not Recruiting